D
RUG DELIVERY by percutaneous permeation is a common approach for administration of chemical therapeutic agents, which may not function well in the gastrointestinal tract or liver due to presystemic metabolism (1, 2) . Chemical absorption into and permeation through the skin plays a key role in both dermatopharmacology and dermatotoxicology (3) . Formulation of the medication, stratum corneum (SC), viable epidermis and dermis (containing circulation post-capillary) constitutes the primary dermatol -transport system.
The SC, the outermost skin layer, is a lipidprotein biphasic membrane structure punctured by protein-filled cronecytes whose chemical nature and geometrical tortuosity contribute to certain levels of diffusional resistance against penetration of substances including outer environmental toxicity and transdermal drugs (4) .
Given the skin's structural and biochemical complexity, and the restrictions of in vivo and even in vitro experiments, mathematical analysis and modeling provide an attractive alternative, which, in spite of assumptions often grossly simplifying, may still offer some insights on the trend and influences of related factors. They have been proved to be valuable.
More specifically, a mathematical model for transdermal diffusion and permeation processes may provide the physics insight on the kinetics characteristics in diffusion and permeation, and the influences of such parameters as the types of chemical agents and the skin properties in both spatial and temporal regimes. So far, most existing models for drug transdermal release employ Fick's first and second laws to explain the release process in complex biological membranes like skin. According to Fick's first law, diffusive flux equals the negative product of the diffusion coefficient and the concentration gradient; here it is
where D ij is the binary diffusion coefficient of the solute i in the solvent j, C i is the concentration of solute i and x is the gradient direction (5).
Kalia and Guy (1) reviewed the mathematical models describing the drug release based on formulation scenarios. Roberts and Anissimov (6) summarized the percutaneous absorption models allowing for various boundary conditions associated with the solute transport across a membrane structure, including clearance from the receptor solution, and from the membrane and diffusion in an underlying layer. Hostynek et al. (7) provided a correlation of in vivo and in vitro percutaneous absorption with a mathematical model. Kubota and Maibach (8) proposed a compartment model, different from the diffusion model in finite-dose percutaneous permeation pharmacokinetics, to predict the lag times and steady-state flux. The intercompartmental transfer rate constants were also defined. Kubota et al. (9) employed a simple single-layer model to specify the permeability coefficient and the drug amount in skin at steady state. The model predicted the longer half-life observed for the split-thickness skin sample compared with that for the epidermis . Kubota and Maibach (10) developed a mathematical three-layer diffusion model and found the lag time and half-life after vehicle removal in epidermis and split-thickness skin were longer than those in the SC without viable layers .
However, the influence of interfaces in a laminated membrane on transfer kinetics has received little attention, due to the assumption that chemical equilibration via portioning is reached quickly enough in such a biphasic system that deeper investigation on to such issues as the interfacial barrier becomes unnecessary. For a rapid interfacial kinetics, a multi-phasic system understandably can be treated as a single-phasic problem (1). However, Albery et al. (11, 12) showed that significant freeenergy barriers exist during transport across a liquid-liquid interface. Once the interphase kinetic rate is slower, the impact of such interfacial barrier is noticeable on the diffusion profile. Hadgraft (13) provided a dimensionless parameter k to describe the rate of transport across an interface to characterize the interfacial kinetics. For an interphase between an organic substrate and an aqueous phase, the transport rate of the interphase
Here k I (m/s) is the interfacial transfer rate of a substance from the organic substrate to the aqueous phase, L is the thickness of the organic layer and D is the diffusivity within the organic layer. For k ) 1, the interfacial transfer term is negligible and the system can be viewed as a single phase; while k 5 1 indicates the interfacial effect dominating the transport characteristics and the interfacial barrier will exert a significant influence on drug release.
Cleek and Bunge (14) employed a finite twomembrane composite model dealing with a system comprising the SC and viable epidermis and an interphase between them. In addition, they found that the concentrations in the SC and viable epidermis at the interphase are related to the partition coefficients.
Actually, transdermal drug delivery is a transport process of drugs through a multi-laminar structure, e.g. from the patch to SC then to the viable epidermis, and finally penetrating into the blood. The process becomes complicated because of the flux barriers between interphases (patch/ SC, SC/viable epidermis). The interphases and their non-uniformity between any neighboring layers usually cause interruptions in transport flux and thus hinder the drug release effectiveness. In addition, an interphase by definition is the contact junction between two different phases, and its properties exhibit more or less some discrete or discontinuous nature, still a difficult problem in numerical modeling. This paper develops a multilayer two dimensional finite-element model to account for effects of the interfacial kinetics on the drug delivery process. The study also develops a contact interface algorithm to deal with interface flux loss. The model assumes the patch is a non-limited reservoir. However, the algorithm can also be applied to the limited reservoir patch.
Model and Algorithms
The structure of the system consists of three parts (i) patch, (ii) SC and(iii) viable epidermis, and the 2D finite-element model is illustrated in Figs 1a and b. Here are the dimensions used in modeling (Table 1) .
For computational consideration, the ratio of the patch length to the skin length of the section for analysis is chosen as 1:10 so that the edge effect can be neglected.
Based on the mass conservation law, we have
where M stored is material originally stored in the whole system, M in-through-boundary and M outthrough-boundary are material moves in and out of the system, M generated is material generated by system during the process. Applying the diffusion equilibrium equation to a unit solid, with no convection flow and no new substances generated due to chemical reactions during the process, we obtain @C @t
Here, C is the concentration, D the diffusion coefficient and t is time.
A 20 h diffusion process is then simulated with the following boundary conditions, S1 : @C @t ¼ 0 and CðtÞ ¼ C 0 ð5aÞ S1; S2; S3; S4; S5; S6; S7; S8; S9; S10 : @c @t ¼ 0
and
and the interphase kinetics boundary conditions,
in which J Interphase 1 and J Interphase 2 are the mass flux at Interphases 1 and 2, the subscripts for C are different interphasic concentrations. Z 1 and Z 2 are the mass transfer coefficients (TCs) (17) . We employed a contact algorithm to deal with interphase kinetics diffusion. For the interface drug diffusion scheme shown in Fig. 2 , a concentration gradient across both contact and target layers is required. Thus the complete variation weak format is, . The patch, stratum corneum and viable epidermis constitute the numerical three-layer model with 10 free surfaces (from S1 to S10) and two Interphases (Interphases 1 and 2) . l T dg T is associated with tangential diffusion and e N dg N with normal diffusion. All simulations are executed in software ANSYS 10.0.
Results
A transient delivery process with the patch maintaining a constant drug concentration is adopted in the present simulations. The time-evolving drug delivery is undergoing in current transient simulations during 20 h. We first calculated and examined the effects of interphase barrier on multiplayer transdermal drug delivery using the interphacial Eqs. (6a) and (6b). For physical parameters in the numerical model, we assumed the diffusion coefficients as shown in Table 1 . To investigate the influence of the interphasic barrier, the TC of Interphase 1 between patch and SC is assigned the values of 0, 100, 1 and 0.001 mm/s, respectively. In addition, the constant concentration of the patch is 1 mg/ml. Figure 3 shows the first case where the transfer coefficient for Interphase 1 5 0 mm/s and Interphase 2 5 100 mm/s so that a patch in the setup does not deliver drug to the skin at all, even after 20 h of physical diffusion time; there is a clear-cut drug concentration gradient with the maximum value at the patch layer and the minimum (0) level at the SC and viable epidermis layers. In other words, since the transfer coefficient is 0, Interphase 11 could not diffuse the drug to Interphase 1 À .
The concentration and flux distribution after 20 h diffusion are shown in Fig. 4 , where the transfer coefficients for both Interphases 1 and 2 are set at 100 mm/s and the drug has been delivered through both Interphases 1 and 2. The concentration gradually declines from the maximum to the minimum with an apparent isocontour distribution of concentration in Fig. 4a . The concentration distribution has high gradient around the corner of patch and SC, where the isocontour line is denser than other locations. The drug flux also shows the maxima at the corners in Fig. 4b .
The iso-contour distributions of drug concentration are an indication of a uniform distribution along both the length and thickness directions, except for the interacting corners between the patch and SC, thus allowing for the comparison of interphase barrier effects with interphase transfer coefficients. For more reliable prediction to avoid various edge effects, the middle section of the patch along the length direction is adopted along which seven characteristic points are chosen as shown in Fig. 5 to calculate and compare the concentration and flux distributions during drug diffusion. Locations 1, 2 and 3 are within the SC layer and Locations 4, 5, 6 and 7 are within the viable epidermis layer.
By setting the transfer coefficient of Interphase 1 at 100.0 mm/s, the drug diffusion concentration curves along the middle path with different interphase transfer coefficients for Interphase 2 are 
Discussion
Transdermal delivery plays an important role in drug administration, where the functionalities of some drug molecules are apt to be offset because of being metabolized in conventional oral approach. In addition, dermal absorption also is a route by which environment chemical hazards can harm the human body. Mathematical models have been established to predict drug transport from the skin to inner organs or to investigate the drug delivery mechanism, examples including those by Guy and Hadgraft (18) More details can be found from the excellent review papers on the subject by Kalia and Guy (1) , and by Roberts and Anissimov (6), successively.
The present paper developed a new interphase contact algorithm using the finite-element method to account for the influences due to the interphase barrier in the whole system. A realistic model for transdermal delivery is established, including the structural layers of the patch, SC and viable epidermis into the finite element. Two interphases between the patch and SC, and between SC and viable epidermis, are identified on which the contact algorithm with the interphase transfer equation is employed.
To verify the interphase contact algorithm of diffusion, we first set the transfer coefficient into 0 of Interphase 1 between the patch and SC layer. The drug diffusion is hence inhibited and the concentrations show only maximum and minimum (0) with no transitional gradient in Fig. 3 . This means the drug in the patch could not transfer to SC because of the null transfer coefficient. The as-expected concentration contours in Fig. 3 have substantiated the feasibility of the algorithm.
Then two non-zero constant transfer coefficients were assumed for both Interphases 1 and 2 in the model, and a 20 h transient diffusion process simulation was executed. As shown in Fig. 4a , the final concentration distributions provide the diffusion profiles at different locations and times around the mid-section of the system. The concentrations have a uniform diffusion front. However, the diffusions around the corner (right angle) between the patch and SC show To examine the effects of interphase barrier on drug delivery, adjustable interphase transfer coefficients are incorporated into the simulations. More specific information can be obtained from Fig. 6 . By altering the transfer coefficients of Interphase 1 between the patch and SC, one can control or fine-tune the diffusion process and the concentration or flux distributions at a given time, which is clearly advantageous for optimal drug effectiveness.
Similar results are shown in Fig. 7 with fixed transfer coefficient 100 mm/s at Interphase 2 and varying values for Interphase 1. Figure 8 also illustrates the influence of the transfer coefficients on the diffusion process, except that the transfer coefficient at Interphase 1 is fixed at 100 mm/s and that for Interphase 1 is allowed to change. The drug flux is much smaller in transfer coefficient 0.01 (Fig. 7b) than in 100 (Fig. 7a) . Also from Fig. 6,  Fig. 7, Fig. 8 , the larger transfer coefficients provided more robust control in the diffusion process.
The simulation results and the interphase contact algorithm in this study demonstrate the possibility of a controllable transdermal drug delivery approach. Furthermore, the algorithm can deal with complicated geometrical conditions, which is difficult for classical analytical solution. We will incorporate these into our future work. Here k 1 and k 2 are parameters related to partition coefficients.
This technique, once further improved by incorporating the partitions coefficients (8a) and (8b) and the other remaining interphase barrier factors into the model and calibrated with experiment data, may provide a robust tool for drug and patch design in transdermal drug delivery applications. Taken together, however, modeling provides but one step, a step that requires experimental validation.
